Innovation1 Biotech OTC Stock Insiders
| IVBT Stock | USD 0 0.00 0.00% |
Innovation1 Biotech employs about 1 people. The company is managed by 2 executives with a total tenure of roughly 3 years, averaging almost 1.0 years of service per executive, having 0.5 employees per reported executive. Breaking down Innovation1 Biotech's management performance can provide insight into the firm performance.
| Tammy Phillips Insider Managing Director |
| Jeffrey Kraws Insider CEO Director |
Innovation1 |
Innovation1 Biotech Management Team Effectiveness
The company has return on total asset (ROA) of (0.0781) % which means that it has lost $0.0781 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.789) %, meaning that it created substantial loss on money invested by shareholders. Innovation1 Biotech's management efficiency ratios could be used to measure how well Innovation1 Biotech manages its routine affairs as well as how well it operates its assets and liabilities.Innovation1 Biotech Workforce Comparison
Innovation1 Biotech is currently regarded as number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 18.0. Innovation1 Biotech holds roughly 1.0 in number of employees claiming about 6% of stocks in Biotechnology industry.
Innovation1 Biotech Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Innovation1 Biotech Price Series Summation is a cross summation of Innovation1 Biotech price series and its benchmark/peer.
Innovation1 Biotech Notable Stakeholders
An Innovation1 Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Innovation1 Biotech often face trade-offs trying to please all of them. Innovation1 Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Innovation1 Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Tammy Phillips | Managing Director | Profile | |
| Jeffrey Kraws | CEO Director | Profile |
About Innovation1 Biotech Management Performance
The success or failure of an entity such as Innovation1 Biotech often depends on how effective the management is. Innovation1 Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Innovation1 management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Innovation1 management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Innovation1 Biotech Inc. operates as a small molecule drug discovery company. The company was founded in 2014 and is based in New York, New York. Innovation1 Biotech operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
The data published in Innovation1 Biotech's official financial statements typically reflect Innovation1 Biotech's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Innovation1 Biotech's quantitative information. For example, before you start analyzing numbers published by Innovation1 accountants, it's essential to understand Innovation1 Biotech's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Please note, the imprecision that can be found in Innovation1 Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Innovation1 Biotech. Check Innovation1 Biotech's Beneish M Score to see the likelihood of Innovation1 Biotech's management manipulating its earnings.
Innovation1 Biotech Workforce Analysis
Traditionally, organizations such as Innovation1 Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Innovation1 Biotech within its industry.Innovation1 Biotech Manpower Efficiency
Return on Innovation1 Biotech Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 40.9M | |
| Net Loss Per Executive | 20.4M |
Additional Tools for Innovation1 OTC Stock Analysis
When running Innovation1 Biotech's price analysis, check to measure Innovation1 Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation1 Biotech is operating at the current time. Most of Innovation1 Biotech's value examination focuses on studying past and present price action to predict the probability of Innovation1 Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation1 Biotech's price. Additionally, you may evaluate how the addition of Innovation1 Biotech to your portfolios can decrease your overall portfolio volatility.